Lumibird Medical

Lumibird Medical

LBIRD.PA
Lannion, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $35M

Market Cap: $570.6MFounded: 2017HQ: Lannion, France

Overview

Lumibird Medical is a global medical device company focused on laser and imaging technologies for ophthalmology and interventional imaging. The company has strategically consolidated three historic brands to create a unified portfolio, leveraging deep laser expertise from its parent group to drive innovation in areas like holographic imaging and portable ultrasound. Its strategy centers on cohesive international growth, a multi-brand approach to address diverse market needs, and expanding its OEM solutions business.

OphthalmologyInterventional Imaging

Technology Platform

Advanced laser and imaging systems for integrated medical devices and OEM components, including holographic Doppler imaging, therapeutic ophthalmic lasers, and portable ultrasound.

Funding History

2
Total raised:$35M
Series B$25M
Series A$10M

Opportunities

Large and growing global markets in ophthalmic devices and point-of-care ultrasound, driven by aging demographics and technological adoption.
The multi-brand and OEM strategies allow penetration of diverse market segments and revenue diversification.
First-mover potential in novel imaging like Doppler holography.

Risk Factors

Integration risks from managing three historic brands under one umbrella.
Intense competition from larger, well-capitalized global medtech players.
Dependence on parent group strategy and capital allocation.
Regulatory and reimbursement challenges across global markets.

Competitive Landscape

Competes with major ophthalmic players (Alcon, Zeiss, Topcon) and portable ultrasound companies (Butterfly, Philips). Differentiates through deep vertical integration in laser tech, a multi-brand portfolio for tiered market access, and a unique OEM solutions business leveraging core IP.

Company Timeline

2017Founded

Founded in Lannion, France

2021Series A

Series A: $10.0M

2022Series B

Series B: $25.0M